Vaccines targeting SARS-CoV-2 tested in humans.

Edwards, Kathryn M

Edwards, Kathryn M.

Edwards KM; Vanderbilt Vaccine Research Program, Vanderbilt University Medical Center, Nashville, TN, USA. kathryn.edwards@vumc.org.

Nat Med ; 26(9): 1336-1338, 2020 09.

Article in English | MEDLINE | ID: covidwho-728993

Subject(s)

Betacoronavirus/immunology; Coronavirus Infections/prevention & control; Immunity, Cellular/immunology; Pandemics/prevention & control; Pneumonia, Viral/prevention & control; Viral Vaccines/therapeutic use; Adolescent; Adult; Betacoronavirus/pathogenicity; COVID-19; Coronavirus Infections/immunology; Coronavirus Infections/virology; Female; Healthy Volunteers; Humans; Immunity, Cellular/drug effects; Male; Middle Aged; Pneumonia, Viral/immunology; Pneumonia, Viral/virology; SARS-CoV-2; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Viral Vaccines / Coronavirus Infections / Pandemics / Betacoronavirus / Immunity, Cellular Topics: Vaccines Limits: Adolescent / Adult / Female / Humans / Male / Middle aged / Young adult Language: English Journal: Nat Med Journal subject: Molecular Biology / Medicine Year: 2020 Document Type: Article Affiliation country: S41591-020-1048-4

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google